Mr. Antal Rohit Desai - 05 Mar 2026 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Reporting relationship: Director
Issuer ticker: PRCT
Reported as of: 05 Mar 2026
Net transaction value: +$10,482,943
SEC form: 4
Accepted by SEC: 09 Mar 2026, 19:19:42 UTC
Prior SEC filing: 15 Aug 2025
Next SEC filing: 10 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Antal Rohit Desai

Key filing fact

Mr. Antal Rohit Desai filed Form 4 for PROCEPT BioRobotics Corp (PRCT) on 09 Mar 2026.

Key facts

This page summarizes Mr. Antal Rohit Desai's Form 4 filing for PROCEPT BioRobotics Corp (PRCT).
7 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 09 Mar 2026, 19:19.

Change

Previous filing in this sequence was filed on 15 Aug 2025.
Current net transaction value: +$10,482,943.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001881616 Primary reporting owner

Desai Antal Rohit

Relationship: Director
Address: C/O PROCEPT BIOROBOTICS CORPORATION, 150 BAYTECH DRIVE, SAN JOSE
Signature: /s/ Antal Rohit Desai
Signature date: 09 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRCT transaction

Common Stock

Purchase

Transaction value: $3,625,021
Shares: +142,498
Change %
Price: $25.44
Shares after: 142,498
Date: 05 Mar 2026
Ownership: Kestrel Fund, L.P.
Footnotes: F1, F2

PRCT transaction

Common Stock

Purchase

Transaction value: $653,528
Shares: +24,748
Change %: +17%
Price: $26.41
Shares after: 167,246
Date: 05 Mar 2026
Ownership: Kestrel Fund, L.P.
Footnotes: F2, F3

PRCT transaction

Common Stock

Purchase

Transaction value: $2,485,713
Shares: +106,554
Change %: +64%
Price: $23.33
Shares after: 273,800
Date: 06 Mar 2026
Ownership: Kestrel Fund, L.P.
Footnotes: F2, F4

PRCT transaction

Common Stock

Purchase

Transaction value: $1,295,790
Shares: +53,763
Change %: +20%
Price: $24.10
Shares after: 327,563
Date: 06 Mar 2026
Ownership: Kestrel Fund, L.P.
Footnotes: F2, F5

PRCT transaction

Common Stock

Purchase

Transaction value: $1,049,500
Shares: +43,581
Change %: +13%
Price: $24.08
Shares after: 371,144
Date: 09 Mar 2026
Ownership: Kestrel Fund, L.P.
Footnotes: F2, F6

PRCT transaction

Common Stock

Purchase

Transaction value: $1,340,348
Shares: +53,818
Change %: +15%
Price: $24.91
Shares after: 424,962
Date: 09 Mar 2026
Ownership: Kestrel Fund, L.P.
Footnotes: F2, F7

PRCT transaction

Common Stock

Purchase

Transaction value: $33,042
Shares: +1,300
Change %: +0.31%
Price: $25.42
Shares after: 426,262
Date: 09 Mar 2026
Ownership: Kestrel Fund, L.P.
Footnotes: F2, F8

PRCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 35,152
Date: 05 Mar 2026
Ownership: Direct

PRCT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 14,363
Date: 05 Mar 2026
Ownership: By The 2:22 DNA Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.0645 to $26.0213, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Footnote F2

CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.10 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.785 to $23.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.79 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Footnote F6

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.40 to $24.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Footnote F7

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.40 to $25.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Footnote F8

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.40 to $25.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.